Nanomalaria joint unit seminar: Konstantinos Mitsakakis, University of Freiburg
LabDisk, a multi-purpose, multi-target diagnostic platform for patient management and surveillance at the point-of-care
Search Results for:
Possible new treatment for bladder cancer using a mycobacterium
Collaborators at the UAB and IBEC have found a mycobacterium that is more effective in treating superficial bladder cancer and does not cause infections, unlike those used up to now.
Mycobacteria are the only bacteria used in cancer treatment. The administration of the bacterium Mycobacterium bovis (BCG) is the current treatment for superficial bladder cancer, and is inserted directly into the bladder through a catheter. BCG prevents new tumours from appearing, but despite its efficacy it has many adverse side effects, the most serious being BCG infections that need to be treated with antituberculous drugs.
‘Submarinos’ en la sangre para llevar el medicamento a las células dañadas
New IBEC junior group leader Lorenzo Albertazzi is profiled in El Mundo’s “Personajes Únicos” section this week.
“Avanza la búsqueda de medicinas personalizadas, incluso para los resfriados”
Last week’s IBEC-organized B·Debate on “Future Tools for Biomedical Research: in vitro, in silico and in vivo Disease Modeling” at CosmoCaixa gained some coverage in the press and on the radio.
IBEC Seminar: Cell Imaging Day – Molecular Probes
Seminar and demonstration by ThermoFisher Scientific
IBEC Seminar: Cell Imaging Day – Molecular Probes
Seminar and demonstration by ThermoFisher Scientific
Safe nanomotors propelled by sugar
Researchers at IBEC and their collaborators have made a breakthrough in nanomotors for applications in medicine by developing the first ever fully biocompatible self-propelling particles that are powered by enzymes that consume biological fuels, such as glucose.
In Nanoletters today, IBEC group leader and ICREA research professor Samuel Sánchez and his collaborators at Max Planck Institute for Intelligent Systems (MPI-IS), the University of Tübingen and the MPI for Solid State Research, describe their fabrication of enzyme-powered synthetic nanomotors that overcome the disadvantages of current systems by being both biocompatible and powered by biologically benign fuels.
Tècnic en Processat de Senyal (Ref. PS-SM)
Application Deadline: 15/10/2015
Ref: PS-SM
El grup de Signal and Information Processing for Sensing Systems de l’Institut de Bioenginyeria de Catalunya (IBEC) requereix incorporar un/-a Tècnic de Recerca per a un projecte industrial en l’àmbit del desenvolupament de detectors químics intel·ligents.
Administratiu/va Comptable (Ref. TC-AG)
Application Deadline: 23/10/2015 — EXTENDED DEADLINE: 15/11/2015 —
Ref: TC-AG
L’Institut de Bioenginyeria de Catalunya (IBEC) requereix incorporar un/-a Tècnic Comptable.
“La física nos podrá enseñar a detener la progresión del cáncer”
Integrative Cell and Tissue Dynamics group leader and ICREA research professor Xavier Trepat has been profiled in El País, where he discusses how combining physics and biology can open new roads to discovering mechanisms that can help us overcome disease, regenerate organs and improve ageing.